0 avis
Validation of the Complexity INdex in SARComas prognostic signature on formalin-fixed, paraffin-embedded, soft-tissue sarcomas
Archive ouverte
International audience.
Background: Prediction of metastatic outcome in sarcomas is challenging for clinical management since they are aggressive and carry a high metastatic risk. A 67-gene expression signature, the Complexity INdex in SARComas (CINSARC), has been identified as a better prognostic factor than the reference pathological grade. Since it cannot be applied easily in standard laboratory practice, we assessed its prognostic value using nanoString on formalin-fixed, paraffin-embedded (FFPE) blocks to evaluate its potential in clinical routine practice and guided therapeutic management.
Methods: A code set consisting of 67 probes derived from the 67 genes of the CINSARC signature was built and named NanoCindVR. To compare the performance of RNA-seq and nanoString (NanoCindVR), we used expressions of various sarcomas (n ¼ 124, frozen samples) using both techniques and compared predictive values based on CINSARC risk groups and clinical annotations. We also used nanoString on FFPE blocks (n ¼ 67) and matching frozen and FFPE samples (n ¼ 45) to compare their level of agreement. Metastasis-free survival and agreement values in classification groups were evaluated.
Results: CINSARC strongly predicted metastatic outcome using nanoString on frozen samples (HR ¼ 2.9, 95% CI: 1.23–6.82) with similar risk-group classifications (86%). While more than 50% of FFPE blocks were not analyzable by RNA-seq owing to poor RNA quality, all samples were analyzable with nanoString. When similar (risk-group) classifications were measured with frozen tumors (RNA-seq) compared with FFPE blocks (84% agreement), the CINSARC signature was still a predictive factor of metastatic outcome with nanoString on FFPE samples (HR ¼ 4.43, 95% CI: 1.25–15.72).
Conclusion: CINSARC is a material-independent prognostic signature for metastatic outcome in sarcomas and outperforms histological grade. Unlike RNA-seq, nanoString is not influenced by the poor quality of RNA extracted from FFPE blocks. The CINSARC signature can potentially be used in combination with nanoString (NanoCindVR) in routine clinical practice on FFPE blocks to predict metastatic outcome.
Consulter en ligne
Suggestions
Du même auteur
